Zacks Small Cap Estimates Cytosorbents Q1 Earnings
Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Analysts at Zacks Small Cap issued their Q1 2025 EPS estimates for Cytosorbents in a research note issued on Friday, April 4th. Zacks Small Cap analyst T. Kerr expects that the medical research company will post earnings per share of ($0.08) for the quarter. The consensus estimate for […]
More Stories
Study: Umbilical Cord Holds Answers to Future Disease
By Amy Denney Genetic information collected from umbilical cords may reveal whether babies are at risk of developing health issues...
Trump Rules Out 3rd Term, Names Rubio and Vance as Best 2028 Contenders
By Rachel Acenas President Donald Trump has shut down speculation about serving a third term and named Vice President JD...
Greenland, Denmark Agree to Strengthen Alliance as Trump Offers to Buy Territory
By Jacob Burg Greenland and Denmark said on April 27 that they will move to solidify their alliance as President...
Warren Buffett Announces Intention to Retire by End of 2025
By Jacob Burg Investor and billionaire Warren Buffett told an arena full of shareholders on May 3 that he will...
US Appeals Court Halts Order Allowing Voice of America Employees Back to Work
By Jack Phillips A U.S. appeals court on Saturday blocked a lower court ruling that ordered the Trump administration to...
NewEdge Advisors LLC Sells 410 Shares of First Community Bankshares, Inc. (NASDAQ:FCBC)
NewEdge Advisors LLC decreased its position in First Community Bankshares, Inc. (NASDAQ:FCBC – Free Report) by 21.3% during the 4th...